Clinical Characteristics of Heart Failure from Case Reports Presented at the Regional Meeting of the Japanese Society of Internal Medicine

Objective To examine case reports presented at the Regional Meeting of the Japanese Society of Internal Medicine in order to clarify the underlying disease and prognosis of heart failure, which is often caused by non-cardiovascular diseases. Methods We examined 49,693 case reports from the Japanese Society of Internal Medicine database. A total of 2,893 reports were included after excluding 46,022 reports that did not include the term “heart failure” and 778 reports with no indications of symptoms of heart failure. We assessed each patient's basal disease, and according to the abstracts, we reported their prognosis as dead or alive. Results Of the 2,893 reports included, 1,952 (67.5%) and 941 (32.5%) had cardiovascular and non-cardiovascular diseases as the causes, respectively; these cases were attributed to 725 different diseases, 196 (27.0%) and 529 (73.0%) of which were cardiovascular and non-cardiovascular diseases, respectively. In addition, 91 different side effects were identified. The percentage of cases of heart failure-related mortality was significantly higher among the patients with non-cardiovascular diseases than in those with cardiovascular diseases (17.8% vs. 10.8%; p <0.001). Of the diseases reported as causes of heart failure in more than 10 reports, pulmonary tumor thrombotic microangiopathy (87%), multiple myeloma (50%), and amyloidosis (47%) accounted for the highest percentages of heart failure-related mortality. Conclusion Because heart failure is often caused by non-cardiovascular diseases, a broad study of case reports on internal medicine is important for cardiologists.

[1]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[2]  A. Takeshita,et al.  Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[3]  H. Shimokawa,et al.  Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan--first report from the CHART-2 study. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Masahiro Ito,et al.  Impending epidemic: future projection of heart failure in Japan to the year 2055. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[5]  Y. Kagaya,et al.  Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Yaw-Bin Huang,et al.  Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients. , 2017, International journal of cardiology.

[7]  Y. Asada,et al.  Pulmonary tumor thrombotic microangiopathy , 1995, Pathology international (Print).

[8]  F. Moeller,et al.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[9]  H. Otto,et al.  Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension , 1990, Cancer.